Avid Bioservices Inc (CDMO)

[keep_trying]

Geo, when PPHM, now CDMO shareholders approved the BOD changes, I recall there was subsequent change in by laws that burned the path used to avoid a repeat BOD change out. In a practical sense, there is no need for the Ronin gang to stay around beyond the time needed to extract their investment at a profit, using the price volatility their actions helped create. There is a common interest with other shareholders if Ronin investments are held in anticipation of announced new Avid business.

Does that some sound like I know what I am talking about? Hardly. Interpreting the past without knowing who were players is only speculative, just as is Avid earnings growth in conjunction with new customer orders. I am still invested, recognizing how Avid growth can and should be getting delivered.

Is a $7 pps analyst price target much of a carrot? It is when trading price is less than half that and Avid growth in sales ought to be able to deliver as projected. CDMO did their placement such that their financials should be solid to support operations for a year + while Avid delivers what sales growth can be found. Using a P/S ratio of 6 and 55 million shares, a 7 pps target would be supported. 7*55 million is $385 million targeted market cap. Dividing by 6 assigns a need for Avid annual sales to reach $64 million. Similarly, a P/S of just 4 suggests a $7 pps price target is supported when Avid sales reach just under $100 million.

Is likelihood of Avid sales reaching and exceeding $64 to $96 million and delivering a $7 pps in a reasonable time frame sufficient to entice keeping Ronin invested in CDMO? How about small retail investors?

Best wishes and IMO.
KT